WNS to Participate at Q2’25 Investor Conferences
The day in focus. Delivered to your inbox.
A concise daily briefing of key stories, insights and developments, selected by our editorial team.
By subscribing, you agree to our Privacy Policy. Unsubscribe at any time.More to Read
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group Plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank Plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Advanced Medical Solutions Group Plc (c) Name of the party to the offer with which exempt principal tra
Form 8.5 (EPT/RI)-Gamma Communications Plc
FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Name of exempt principal trader: Investec Bank plc (b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Gamma Communications Plc (c) Name of the party to the offer with which exempt principal trader is conne
CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF GBP 500,000,000 Subordinated Fixed Rate Resettable Notes issued on 9 June 2021 (ISIN: FR0014003W84)*
Montrouge, November 10, 2026 CREDIT AGRICOLE S.A. ANNOUNCES REDEMPTION OF GBP 500,000,000 Subordinated Fixed Rate Resettable Notes issued on 9 June 2021 (ISIN: FR0014003W84)* Crédit Agricole S.A. (the “ Issuer” ) announces today the redemption (the “ Redemption” ) with effect on 9 December 2026 (the “ Redemption Date” ) of all of its outstanding GBP 500,000,000 Subordinated Fixed Rate Resettable Notes issued on June 9, 2021 (ISIN: FR0014003W84) (the “ Notes” ) pursuant to Condition 6(e) ( Redemp
4BIO Capital leads $60M Series A financing of Oyster Therapeutics (formerly Kesmalea Therapeutics) to advance next-generation targeted protein degraders for Alzheimer’s and other neurodegenerative diseases
Proceeds to advance oral, brain-penetrant tau degrader into clinical development as a novel treatment for tau-driven diseases like Alzheimer’s Series A led by 4BIO Capital with participation from new investors, including Eli Lilly and Company, alongside existing investors Financing supports continued development of proprietary SELFTAC ® platform for generating small bifunctional targeted protein degraders with enhanced drug-like properties Establishes collaboration with leading tau researcher Dr
NBPE Announces Transaction in Own Shares
THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS Neuberger Private Equity Partners Announces Transaction in Own Shares St Peter Port, Guernsey 10 November 2026 Neuberger Private Equity Partners Limited (“NBPE” or the “Company”) today announces details of Class A Shares bought back pursuant to general authority granted by shareholders of the Company on 1
Progress on share buyback programme
Progress on share buyback programme ING announced today that, as part of our €1.65 billion share buyback programme announced on 29 October 2026, in total 2,755,000 shares were repurchased during the week of 2 November up to and including 6 November 2026. The shares were repurchased at an average price of €28.64 for a total amount of €78,909,413.50. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the updates on the share buy
GTN appoints former Gemini and Kraken executive Mark Jennings as global head of digital assets
New role to lead GTN s tokenisation strategy as more platforms bring traditional assets on-chain DUBAI, UAE , Nov. 10, 2026 -- G T N , the global fintech powering limitless investment, today announced the appointment of Mark Jennings as global head of digital assets. Mark will lead GTN s strategy to support tokenised securities through its global market access. Mark joins GTN from Gemini, where, as CEO of Gemini Europe, he led the exchange s European expansion. Before that, he held senior roles at Kraken, including CEO of Crypto Facilities, its FCA-regulated derivatives venue for institutional clients.
Burn-related claims peak in the Diwali quarter, Star Health data shows; insurer shares simple safety steps
Quick media bites Burn-related claims reported in Q3 (October December) were 28% above the average of the other three quarters in FY26, compared with 19% in FY25 Star Health sets out preventive steps and first-aid guidance for burns and eye injuries, with a reminder to seek prompt medical help after any firecracker injury CHENNAI, India , Nov. 10, 2026 -- As families gather for Diwali, Star Health and Allied Insurance Company Limited (NSE: STARHEALTH) (BSE: 543412) urges them to celebrate with a safety-first approach. Its claims data shows burn-related claims in the festive quarter running 28% above the average of the other three quarters in FY26, and the insurer is sharing simple precautions and first-aid guidance to keep the season joyful.
Comments (0)
Login to join the conversation
Login / RegisterNo comments yet. Be the first to comment!